The following pages link to Neurofibromatosis type 2. (Q30391375):
Displaying 50 items.
- Genomic restructuring in the Tasmanian devil facial tumour: chromosome painting and gene mapping provide clues to evolution of a transmissible tumour (Q21144931) (← links)
- A neuronal function of the tumor suppressor protein merlin (Q26830181) (← links)
- The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment (Q27025661) (← links)
- A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation (Q27301307) (← links)
- Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation (Q27304868) (← links)
- Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas. (Q27853117) (← links)
- Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy (Q28078129) (← links)
- Discovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms (Q28087577) (← links)
- The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version (Q28281214) (← links)
- Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas (Q30301216) (← links)
- Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas (Q30359059) (← links)
- Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies. (Q30364937) (← links)
- Latent Progression Pediatric Scrotal Schwannoma. A Case Report. (Q30383928) (← links)
- Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors (Q30391370) (← links)
- Neurofibromatosis type 2 patient presenting with medulloblastoma (Q30399531) (← links)
- Neurofibromatosis 2 invasion of the internal auditory canal wall: clinical significance (Q30402090) (← links)
- Imatinib in neurofibromatosis type 2. (Q30407175) (← links)
- Superior temporal resolution of Chronos versus channelrhodopsin-2 in an optogenetic model of the auditory brainstem implant (Q30409319) (← links)
- Novel insight into mutational landscape of head and neck squamous cell carcinoma (Q30441193) (← links)
- Incidental parenchymal magnetic resonance imaging findings in the brains of patients with neurofibromatosis type 2. (Q30443355) (← links)
- Pooled analysis of case-control studies on acoustic neuroma diagnosed 1997-2003 and 2007-2009 and use of mobile and cordless phones (Q30447089) (← links)
- Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features (Q30451619) (← links)
- Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants (Q30457595) (← links)
- Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: from bench to bedside (Q30458310) (← links)
- Mechanisms of hearing loss in neurofibromatosis type 2. (Q30462725) (← links)
- Incidence trends of vestibular schwannomas in Denmark, Finland, Norway and Sweden in 1987-2007. (Q30463368) (← links)
- Temporal bone histopathology in neurofibromatosis type 2. (Q30466218) (← links)
- Hereditary Genodermatoses with Cancer Predisposition (Q30470596) (← links)
- Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function (Q30474083) (← links)
- Multiple primary cranio-spinal tumours in a 13-year-old female with neurofibromatosis type 2 management strategy (Q30477143) (← links)
- Tumor suppressor NF2/Merlin is a microtubule stabilizer (Q30572320) (← links)
- Neuroimaging of pediatric posterior fossa tumors including review of the literature (Q34046892) (← links)
- Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas (Q34062012) (← links)
- Morbidity in survivors of child and adolescent meningioma (Q34402586) (← links)
- Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis (Q35047921) (← links)
- Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells (Q35601012) (← links)
- Negative regulation of Yap during neuronal differentiation (Q35605297) (← links)
- A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis (Q35829995) (← links)
- Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism (Q35836025) (← links)
- Is Simpson grade I removal necessary in all cases of spinal meningioma? Assessment of postoperative recurrence during long-term follow-up (Q35943475) (← links)
- Neuron-Specific Deletion of the Nf2 Tumor Suppressor Impairs Functional Nerve Regeneration. (Q36088696) (← links)
- Role of Merlin/NF2 inactivation in tumor biology (Q36189820) (← links)
- Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells (Q37122075) (← links)
- Intrascrotal and extratesticular multiple schwannoma (Q37165054) (← links)
- Alternatives to surgical approach for giant spinal schwannomas (Q37577282) (← links)
- The Diagnostic and Clinical Significance of Café-au-lait Macules (Q37796203) (← links)
- The Hippo pathway in biological control and cancer development (Q37800053) (← links)
- Response Assessment in Neuro-Oncology (Q37810523) (← links)
- Snapshots of a hybrid transcription factor in the Hippo pathway (Q37825816) (← links)
- Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation (Q37880216) (← links)